Nothing is like Adequan® i.m.
  • The only FDA-approved Polysulfated Glycosaminoglycan on the market
  • Indicated to reverse joint damage and improve joint function through intramuscular injection
  • Backed by FDA-approved efficacy and safety studies
  • Made under strict Good Manufacturing Practices for a safe, consistent product every time
  • Very unique active ingredient and manufacturing facilities
Back to
Home page
To learn more and for full prescribing information go to adequan.com
Brief Summary Indications: For the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses. There are no known contraindications to the use of intramuscular Adequan® i.m. brand Polysulfated Glycosaminoglycan in horses. Studies have not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children. Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Each 5 mL contains 500 mg Polysulfated Glycosaminoglycan. SEE PRODUCT PACKAGE INSERT FOR FULL PRESCRIBING INFORMATION. Adequan® is a registered trademark of Luitpold Pharmaceuticals, Inc. ©LUITPOLD PHARMACEUTICALS, INC., Animal Health Division, Shirley, NY 11967. AHD 1530, Iss. 2/12 Chondroprotec® is a registered trademark of Neogen Corporation. Ichon® is a registered trademark of kinetic Technologies. PentAussie® is a registered trademark of Nature Vet pty. ltd. Polyglycan® is a registered trademark of ArthroDynamic Technologies, inc.